Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of MRVI Maravai Lifesciences | -13.2% in 12m

Compare MRVI with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Maravai Lifesciences with its related Sector/Index XLV

Compare Maravai Lifesciences with its related Sector/Index XLV

Performance Duell MRVI vs XLV

TimeFrame MRVI XLV
1 Week 0.00% -2.07%
1 Month -0.44% 4.37%
3 Months 6.97% 5.66%
6 Months 24.3% 6.23%
12 Months -13.2% 17.65%
YTD 34.3% 11.77%
Rel. Perf. 1m -0.88
Rel. Perf. 3m 0.45
Rel. Perf. 6m 0.60
Rel. Perf. 12m 0.60
Spearman 1m 0.33 0.82
Spearman 3m 0.62 0.89

Is Maravai Lifesciences a good stock to buy?

Probably not. Based on ValueRay Fundamental Analyses, Maravai Lifesciences (NASDAQ:MRVI) is currently (September 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -32.96 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MRVI as of September 2024 is 8.49. This means that MRVI is currently overvalued and has a potential downside of -6.19% (Sold with Premium).

Is MRVI a buy, sell or hold?

  • Strong Buy: 7
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
Maravai Lifesciences has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy MRVI.
Values above 0%: MRVI is performing better - Values below 0%: MRVI is underperforming

Compare MRVI with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 4.14% -3.93% 17.63% -35.33%
US NASDAQ 100 QQQ 5.79% -2.52% 21.76% -33.00%
US Dow Jones Industrial 30 DIA 2.82% -4.24% 19.01% -31.65%
German DAX 40 DBXD 3.24% -5.84% 21.48% -27.75%
UK FTSE 100 ISFU 2.25% -6.71% 11.99% -31.31%
Shanghai Shenzhen CSI 300 CSI 300 2.68% 1.87% 30.58% -2.24%
Hongkong Hang Seng HSI 2.22% -5.21% 23.80% -7.31%
Japan Nikkei 225 EXX7 7.12% -6.12% 34.44% -19.01%
India NIFTY 50 INDA 2.10% -3.05% 15.87% -37.46%
Brasil Bovespa EWZ 1.71% -7.32% 32.82% -13.39%

MRVI Maravai Lifesciences vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 4.07% -1.03% 16.94% -37.67%
Consumer Discretionary XLY 2.52% -5.83% 22.32% -19.24%
Consumer Staples XLP -0.58% -6.51% 12.49% -31.30%
Energy XLE 5.77% 0.68% 23.99% -11.01%
Financial XLF 3.17% -7.16% 14.41% -43.89%
Health Care XLV 2.07% -4.81% 18.08% -30.80%
Industrial XLI 4.24% -3.59% 20.10% -34.22%
Materials XLB 4.66% -2.03% 22.21% -24.80%
Real Estate XLRE -0.18% -5.45% 12.54% -36.52%
Technology XLK 7.45% -2.10% 25.56% -31.47%
Utilities XLU 0.50% -4.61% 2.19% -36.91%
Aerospace & Defense XAR 5.21% -4.44% 19.84% -39.49%
Biotech XBI 4.68% -2.64% 27.79% -35.76%
Homebuilder XHB 4.40% -3.86% 16.47% -50.75%
Retail XRT 4.98% 0.07% 27.56% -31.80%

MRVI Maravai Lifesciences vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 7.28% 4.42% 31.59% -1.10%
Natural Gas UNG -7.11% -7.95% 41.49% 33.50%
Gold GLD 0.29% -4.94% 8.30% -42.42%
Silver SLV 3.30% -3.85% 9.02% -33.57%
Copper CPER 3.42% -1.43% 18.74% -21.60%

Returns of MRVI vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -3.51% -3.85% 18.50% -23.68%
iShares High Yield Corp. Bond HYG -0.72% -3.54% 18.24% -26.24%
Does Maravai Lifesciences outperform its market, is MRVI a Sector Leader?
No, over the last 12 months Maravai Lifesciences (MRVI) made -13.15%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months MRVI made 6.97%, while XLV made 5.66%.
Period MRVI XLV S&P 500
1 Month -0.44% 4.37% 3.49%
3 Months 6.97% 5.66% 1.39%
12 Months -13.15% 17.65% 22.18%